LILRB3
Leukocyte immunoglobulin-like receptor subfamily B member 3
Also known as: CD85a, HL9, ILT5, LIR-3, LIR3, LIRB3_HUMAN, PIR-B, PIRB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75022
- Gene
- LILRB3
- Ensembl
- ENSG00000204577
- Chromosome
- 19
- Canonical length
- 631 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
631 residues, UniProt reviewed canonical sequence.
>O75022|LILRB3
1 MTPALTALLC LGLSLGPRTR VQAGPFPKPT LWAEPGSVIS WGSPVTIWCQ GSQEAQEYRL
61 HKEGSPEPLD RNNPLEPKNK ARFSIPSMTE HHAGRYRCHY YSSAGWSEPS DPLEMVMTGA
121 YSKPTLSALP SPVVASGGNM TLRCGSQKGY HHFVLMKEGE HQLPRTLDSQ QLHSRGFQAL
181 FPVGPVTPSH RWRFTCYYYY TNTPWVWSHP SDPLEILPSG VSRKPSLLTL QGPVLAPGQS
241 LTLQCGSDVG YNRFVLYKEG ERDFLQRPGQ QPQAGLSQAN FTLGPVSPSN GGQYRCYGAH
301 NLSSEWSAPS DPLNILMAGQ IYDTVSLSAQ PGPTVASGEN VTLLCQSWWQ FDTFLLTKEG
361 AAHPPLRLRS MYGAHKYQAE FPMSPVTSAH AGTYRCYGSY SSNPHLLSHP SEPLELVVSG
421 HSGGSSLPPT GPPSTPGLGR YLEVLIGVSV AFVLLLFLLL FLLLRRQRHS KHRTSDQRKT
481 DFQRPAGAAE TEPKDRGLLR RSSPAADVQE ENLYAAVKDT QSEDRVELDS QSPHDEDPQA
541 VTYAPVKHSS PRREMASPPS SLSGEFLDTK DRQVEEDRQM DTEAAASEAS QDVTYAQLHS
601 LTLRRKATEP PPSQEGEPPA EPSIYATLAI HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LILRB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- spleen: 38 nTPM
- lung: 19 nTPM
- bone marrow: 12 nTPM
- adipose tissue: 7.2 nTPM
- appendix: 6.8 nTPM
- blood vessel: 4.2 nTPM
Single-cell type
- neutrophils: 61 nCPM
- monocytes: 21 nCPM
- macrophages: 5.9 nCPM
- cdc: 4.8 nCPM
- hofbauer cells: 4.6 nCPM
- neutrophil progenitors: 2.5 nCPM
Immune cell
- neutrophil: 43 nTPM
- classical monocyte: 15 nTPM
- intermediate monocyte: 15 nTPM
- total PBMC: 11 nTPM
- myeloid DC: 7.2 nTPM
- non-classical monocyte: 6 nTPM
Brain region
- thalamus: 4.5 nTPM
- cerebral cortex: 4.1 nTPM
- pons: 2.9 nTPM
- white matter: 2.9 nTPM
- medulla oblongata: 2.7 nTPM
- choroid plexus: 2.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LILRB3.
Disease | ImmuneIEDB
Conditions an epitope on LILRB3 was assayed in.
- colonic benign neoplasm T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.01
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cell surface receptor signaling pathway
- cytokine-mediated signaling pathway
- defense response
- immune response-regulating signaling pathway
- negative regulation of osteoclast differentiation
Molecular functions
- inhibitory MHC class I receptor activity
- signaling receptor activity
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LILRB3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LILRB3 as an antibody target. Whether an autoantibody or antibody against LILRB3 could matter depends on whether native LILRB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LILRB3 is annotated at the cell surface, where native LILRB3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LILRB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...